Kevyn Matijevich, RQAP-GCP, is Associate Director, Research and Development (R&D), Clinical Quality Assurance at Menarini Stemline. In this role, Ms. Matijevich is responsible for supporting oncology research trials. Ms. Matijevich is registered with the Society of Quality Assurance in Good Clinical Practices (RQAP-GCP) and holds a Master’s certificate in regulatory affairs from the University of Georgia. She has more than 20 years of quality experience within the pharmaceutical/life sciences industry. She has extensive experience in quality systems, computer systems validation, risk based quality management, process improvement, change management, auditing, vendor management, and electronic records/signature regulations. Additionally, Ms. Matijevich is the SQA CVIC AVA subcommittee chair and is the past president of the North Carolina Chapter of the Society of Quality Assurance board.
Archives: Speakers
Willy Burkhardt
Willy Burkhardt, former Finwave CEO is now in charge of the international development of Fibonacci Group.
Finwave is now part of Fibonacci Group, an international software company that operates in the financial sector offering vertical solutions for factoring, leasing and consumer credit.
Experienced Enterpreneur and Managing Director with a demonstrated history of working in the IT and services industry.
Skilled in Management of Listed Companies and Start-ups, Integration, and Business Strategy.
Jon Lee
Debra Caballero
Debra Caballero is an accomplished consultative sales and business development leader with over 25 years dedicated to the life sciences/clinical trial logistics space.
Her passion for new and innovative products and processes in the logistics world enables cutting edge therapies and streamlines the journey of medicines from clinical to commercial.
As VP of Revenue at Life Couriers, Debra’s responsibilities are to bring customizable solutions and forward-thinking processes to the pharmaceutical and life science world, to support the challenges new therapies and medicines carry with them.
Areas of Expertise
- Clinical trials
- Healthcare logistics
- Team leadership
- Sales strategy
- New technology in healthcare logistics
Career
2024 – today: VP Revenue, Life Couriers
2023 – 2024: Business Development Director, Clinigen Clinical Supplies Management
2020 – 2023: Sr Manager Sales Support & Quote Teams North America, World Courier
2006 – 2020: Director of Business Development, MidWest, World Courier
Matt Silverberg
Matt Silverberg has been a leader in the logistics and transportation industry for over a decade. His work is characterized by a strategic way of thinking, a visionary view and transformative leadership.
Since 2024, the experienced executive has led the commercial business of Life Couriers as CCO, driving further development and expansion of the business in the US region. In his previous role as CEO of Associated Couriers, his dedication and customer focus built strong relationships with customers and partners, continually raising the standard for logistics and courier services. Life Couriers is one of the global leaders of healthcare and life science logistics with many years of experience in the field.
“The logistics sector is a fast-paced environment that demands a willingness to constantly evolve and refine our practices. In healthcare logistics, where a delivery can directly impact a patient’s life, we stand to gain significantly from innovations and new technologies. And it’s crucial not only to generate new ideas but also to effectively implement them in real-world scenarios.”
Areas of Expertise
- Healthcare Logistics
- Final Mile
- Leadership in the Logistics Industry
- New technology in healthcare logistics
Career
2023 – today: CCO, Life Couriers
2018 – 2023: CEO Associated Couriers
2017 – 2018: COO Associated Couriers
2015 – 2017: Director Operations Associated Couriers
2013 – 2015 Operations Manager Associated Couriers
Tom Spangler
Tom Spangler has more than 30 years of experience in CAD and PLM, including 15 years in design, IT, and data management in the automotive industry at both the OEM and supplier levels. Tom completed his master’s degree in business administration in 2006 and joined Siemens in 2008 as a marketing manager. In that role he has created and contributed to multiple product launches, marketing campaigns, and other initiatives.
Jan Modregger
Dr. Jan Modregger holds a PhD in Physiological Chemistry from the University of Cologne, Germany, and worked as a research associate at the Howard Hughes Medical Institute at Yale University, New Haven. In 2010, Dr. Modregger received a fellowship for the executive MBA program of the Institute for Management, Salzburg and completed his MBA in 2013.
After serving EUCODIS Bioscience as Head of Research and Development and CEO for several years, Dr Modregger is currently leading the Biocatalysis teams of Biosynth, responsible for enzymes, biocatalysis and fermentation processes. In this role, he promotes the transformation of classical chemical processes into sustainable, enzyme-based processes using microbial systems and renewable resources within the organization and in customer projects.